Back to top
more

Vanguard Consumer Discretionary ETF: (VCR)

(Delayed Data from NYSE) As of Aug 23, 2024 04:00 PM ET

$322.24 USD

322.235
23,710

+6.38 (2.02%)

Volume: 23,710

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

3 - Hold of 5     3    

After-Market: $322.51 +0.28 (0.09 %) 7:58 PM ET

Zacks News

Sanghamitra Saha headshot

10 Top-Performing ETFs of the Past Decade

These ETFs have emerged as one of the top performers in the past decade.

Sweta Jaiswal, FRM headshot

6 ETFs to Consider as Thanksgiving Week Begins

Let's look at some ETFs that are expected to benefit from consumer shopping and celebrations as the Thanksgiving week begins.

Sweta Killa headshot

Sector ETFs & Stocks to Buy This November

November has been the second-best month for the Dow Jones since 1950, the Nasdaq since 1971 and Russell 2000 since 1979. The month is the best for the S&P 500 since 1950.

Sweta Jaiswal, FRM headshot

ETF Areas to Gain From the Holiday Shopping Season

Here we highlight some ETF areas that are well-positioned to gain from a busy shopping season this year despite the coronavirus crisis.

Sweta Jaiswal, FRM headshot

Will ETFs Gain on Starbucks' Q4 Earnings Beat Amid Pandemic?

Starbucks' Q4 earnings release look encouraging on better-than-expected earnings results amid the coronavirus crisis.

Sweta Jaiswal, FRM headshot

Will Coronavirus Vaccine & Treatment Optimism Drive These ETFs?

The coronavirus vaccine and treatment progress can bring back optimism for some ETFs, which are largely affected by the outbreak-led slowdown in economic activities.

Sweta Killa headshot

5 ETFs to Buy on Amazon's Blowout Q3

Amazon once again posted record profit and revenues buoyed by a massive boost from the accelerated adoption of e-commerce amid the COVID-19 pandemic.

Sweta Jaiswal, FRM headshot

Will ETFs Gain on Upbeat US Consumer Sentiments in October?

Let's look at the impact of positive preliminary U.S. consumer sentiment data on the consumer discretionary sector, which attracts a major portion of consumer spending.

Sweta Killa headshot

Biden or Trump, These 4 ETF Zones Are Set to Gain

Investors are preparing to reposition their portfolio heading into the election, which is just less than four weeks away.

Sweta Jaiswal, FRM headshot

ETFs to Gain on Upbeat US Consumer Confidence in September

Strengthening consumer confidence can benefit the consumer discretionary sector, which attracts a major portion of consumer spending.

Sweta Jaiswal, FRM headshot

Top 5 ETFs of the Best-Performing S&P 500 Sector in Q3

The reopening of the U.S. economy and encouraging economic data saw investors giving attention to cyclical stocks in Q3, with the consumer discretionary sector being the star performer.

Sweta Jaiswal, FRM headshot

Winning ETF Areas After First Presidential Debate

Here we look at ETF areas that appear to be winning after the recently-concluded presidential debate.

Sweta Jaiswal, FRM headshot

ETF Areas to Consider This Cursed September Amid Coronavirus

Let's look at some ETF areas one can consider investing in for a smooth sail amid the turbulences September can usher in.

Sanghamitra Saha headshot

Is a September Lull Inevitable? Play 6 ETFs

The S&P 500 posted its worst single-session drop in nearly three months mainly on profit booking. While high-flying tech names were hurt the most, laggards are better-positioned.

Sweta Jaiswal, FRM headshot

Amazon ETFs to Gain on FAA Approval for Prime Air Drone Delivery

Amazon's receipt of an approval from the FAA allowing it to test commercial deliveries through its drone fleet seems to be well-timed as the company sees huge demand amid the coronavirus crisis.

Sweta Jaiswal, FRM headshot

Cyclical ETFs to Gain on Vaccine Progress & Market Optimism

Major cyclical sectors like the industrial, financial, energy and consumer discretionary may make the most of the reopening of U.S. economy and notable progress in the coronavirus vaccine development.